Delivery Order SPE2DB24D2205-SPE2DB25FEFME
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,160.01 to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. ENBREL is a biologic immunosuppressant commonly used to treat rheumatoid arthritis, psoriasis, and other autoimmune...
- The Defense Logistics Agency awarded a delivery order valued at $38,403.45 to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of July 29, 2025. This competitive, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. ENBREL is a biologic immunosuppressant used to treat rheumatoid arthritis, psoriasis, and other...
- The Defense Logistics Agency awarded a delivery order valued at $22,877.90 to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injectors. The contract, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a firm fixed-price procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,592.67 to AmerisourceBergen Drug Corp for the supply of ENBREL 50 mg/ml SureClick auto-injectors. This non-set-aside, competitively awarded contract was executed on July 21, 2025, with an ultimate completion date of July 22, 2025, and reflects a firm fixed price arrangement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $37,508.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injector pens. This competitively awarded contract, which carries no set-aside designation, was finalized on July 24, 2025, with an ultimate completion date of July 25, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Enbrel is a biologic immunosuppressant commonly prescribed for rheumatoid...
- The Defense Logistics Agency awarded a delivery order valued at $42,776.04 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors. The contract, awarded on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a firm fixed-price procurement with no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $7,887.13 to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with an ultimate completion date of July 28, 2025. This non-competitive delivery order represents a firm fixed-price transaction issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $13,844.92 delivery order to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. This non-set-aside, competitively awarded contract utilized firm fixed pricing and was completed on July 24, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of the company's established role as a critical pharmaceutical supplier to the...
- The Defense Logistics Agency awarded a $35,063.69 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors, with an ultimate completion date of July 24, 2025. This is a firm fixed-price delivery order issued under a competitive process with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving critical federal medical procurement needs, particularly for military and...
- The Defense Logistics Agency awarded a $35,070.68 firm fixed price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injectors, with an ultimate completion date of July 23, 2025. This non-set-aside contract was competitively awarded on July 22, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFMEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at approximately $82.1K to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. ENBREL is a biologic immunosuppressant used to treat rheumatoid arthritis, psoriasis, and other inflammatory conditions, and the SureClick delivery system is a pre-filled auto-injector designed for patient self-administration. This delivery order represents a task order issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.9M and runs through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement across the Defense Health Agency and other military healthcare systems. The SPE2DX vehicle functions as a comprehensive global pharmaceutical support contract enabling the supply of specialty medications, brand-name and generic drugs, vaccines, and related medical supplies to military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $82.1k | 7/28/25 |